Congratulations Rubix LS on securing $1.25M Seed Round of Financing!


Congratulations to Reginald Swift and the Rubix LS team on securing $1.25 million Seed round of financing to advance their virtual clinical trial platform, StarSense. "We're ensuring that we don't let the pandemic and any further instances of innovation disregard the underrepresented communities from accessing therapies for conditions and start building trust among the communities at large." - Reginald Swift, Founder & CEO of Rubix LS To visit Rubix LS's website and learn more, click here. To book an online tour with C2I Accelerator, click here.


Featured Posts
Recent Posts
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • LinkedIn Social Icon

© 2019 by CreaGen Inc. 

299 Washington St

Woburn, MA 01801 

Tel: 781.938.1122

Fax: 781.938.1123

 

info@creagenbio.com

  • Grey LinkedIn Icon
  • Grey Twitter Icon
  • Grey YouTube Icon
  • Grey Facebook Icon

Business Accelerator | CreaGen C2I | Life Science | Lease Lab Space | Biotech